See how new AI tech is helping to make connections between diseases once thought to be unrelated, unlock treatment options, and usher in a new era of drug discovery.
Interested in exploring how AI can transform your industry or business? Just hit reply to schedule a demo of a customizable AI solution.
What is AI-Powered Immunoscience?
AI-Powered Immunoscience is a field that combines artificial intelligence with the study of the immune system to understand and treat diseases more effectively. Companies like Sanofi are leveraging AI to accelerate research, identify connections between diseases, and develop new treatment options. This approach aims to reshape how we address various health challenges, including mental health and non-communicable diseases.
How is AI transforming drug development?
AI is transforming drug development by enabling faster and more accurate clinical trials through in silico trials, which use simulations to evaluate new medicines before human testing. This technology helps researchers identify optimal treatment paths and reduces the time and resources spent on unsuccessful drug candidates. Sanofi, for example, has reported a significant reduction in development time due to AI-driven insights.
What impact does AI have on rare diseases?
AI is expected to enhance treatment options for rare diseases by enabling more precise and targeted therapies. Currently, only 5% of known rare diseases have available treatments, but AI can help identify potential therapies and streamline the development process. This could lead to better care for the estimated 300 million people worldwide living with rare conditions, ensuring fewer patients fall through the cracks.
Sign in with LinkedIn